Green Thumb IndustriesGTBIF +1.08%85 Net Margin % is 5.13% as of Mar. 2026, which is 49% above its 10-year median of 3.44. GuruFocus rates GTBIF with a GF Score™ of 85/100 and a GF Value™ of $8.89 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Green Thumb Industries ranks better than 65.17% on this metric.
The historical rank and industry rank for Green Thumb Industries's Net Margin % or its related term are showing as below:
GTBIF'
s Net Margin % Range Over the Past 10 Years
Min: -27.31 Med: 3.44 Max: 10.17
Current: 10.17
GTBIF's Net Margin % is ranked better than 65.17% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs GTBIF: 10.17
Green Thumb Industries (OTCPK:GTBIF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Green Thumb Industries Net Margin % Related Terms
Green Thumb Industries Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Thumb Industries Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Net Margin % distribution charts can be found below:
* The bar in red indicates where Green Thumb Industries's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Thumb Industries (GTBIF) has a Net Margin % of 5.13% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Green Thumb Industries and its competitors. This is 49% above median its historical median of 3.44. According to the industry distribution chart, Green Thumb Industries ranks #333 out of 956 companies in the Drug Manufacturers industry, placing it in the top 34.8%.
Is Green Thumb Industries' Net Margin % too high?
Green Thumb Industries' current Net Margin % of 5.13% is 49% above median its 10-year median of 3.44. The Drug Manufacturers industry median Net Margin % is 5.56. Green Thumb Industries' value of 5.13% is 7.7% below this industry median. Based on the distribution chart, Green Thumb Industries ranks #333 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Green Thumb Industries has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Green Thumb Industries' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Green Thumb Industries ranks #333 out of 956 companies for Net Margin %. This puts Green Thumb Industries in the upper half of its industry. The industry median Net Margin % is 5.56. Green Thumb Industries' value of 5.13% is 7.7% below this benchmark. While the company's 10-year median is 3.44 vs. the industry median of 5.56, Green Thumb Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Thumb Industries's current Net Margin % of 5.13% is 7.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Green Thumb Industries and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Thumb Industries's current Net Margin % is 5.13%, which is 49% above median its own 10-year median of 3.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Thumb Industries stock overvalued right now?
Based on GuruFocus' analysis, Green Thumb Industries (GTBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.89, compared to a current price of $7.47 — trading 16% below its estimated fair value. The current Net Margin % is 5.13%, which is 49% above median its 10-year median of 3.44 and 7.7% below the Drug Manufacturers industry median of 5.56. Green Thumb Industries' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Green Thumb Industries (GTBIF), the current Net Margin % is 5.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Thumb Industries (GTBIF) Overvalued in 2026?
Based on GuruFocus' analysis, Green Thumb Industries stock appears to be undervalued.
The current stock price of $7.47 is trading 16% below its estimated GF Value™ of $8.89.
GuruFocus considers Green Thumb Industries to be Modestly Undervalued.
Key valuation signals for GTBIF:
Net Margin %: 5.13% (49% above median its 10-year median of 3.44)
GF Value™: $8.89 vs. price of $7.47 (16% below fair value)
Industry Position: 7.7% below the Drug Manufacturers median (#333 of 956)
No single metric tells the full story. See the GTBIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
85GF Score
Get the complete analysis for GTBIF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GTBIF has been successfully added to your 
